Daniel Kantor
Neurology · Coconut Creek, FLNPI 1881637858
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 21.4%. Reporting peaked in 2019 at $125,009 and has fallen 99.9% since, to $150 in 2025. Among neurology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 203 payments — averaging $1135.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$49K
- Avanir Pharmaceuticals, Inc.$48K
- Bristol Myers Squibb$42K
- E.r. Squibb & Sons, L.L.C.$14K
- Sanofi$14K
- EMD Serono, Inc.$12K
- plus $52K from 12 others
Across 30 payments — averaging $26,203 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$750K
- Janssen Research & Development, LLC$19K
- Novartis$8K
- Sanofi$4K
- F. Hoffmann-la Roche AG$3K
- Sanofi-aventis U.S. LLC$1K
What the payments were for
- Consulting fees$79,67135%
- Speaking & faculty fees$126,69955%
- Travel & lodging$20,2249%
- Food & beverage$3,8462%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 64 | $49,379 |
| Avanir Pharmaceuticals, Inc. | 27 | $48,304 |
| Bristol Myers Squibb | 23 | $41,692 |
| E.r. Squibb & Sons, L.L.C. | 9 | $13,589 |
| Sanofi | 11 | $13,501 |
| EMD Serono, Inc. | 8 | $12,466 |
| Mylan Specialty L.p. | 18 | $11,029 |
| Novartis | 5 | $9,636 |
| Sandoz | 6 | $8,061 |
| AbbVie | 4 | $6,569 |
| Greenwich Biosciences, Inc. | 8 | $6,407 |
| Janssen Global Services, LLC | 7 | $4,986 |
| Biogen | 7 | $3,041 |
| Tersera Therapeutics LLC | 1 | $750 |
| ZOLL Medical Corporation | 1 | $750 |
| Amneal Pharmaceuticals LLC | 2 | $218 |
| Vanda Pharmaceuticals Inc. | 1 | $40 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$230,440 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Phenobarbital | 12 | $92 |
Paid to pharmacies, not to this prescriber.
Other neurology in Coconut Creek
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Matthew BakerNaples$1.4M
- Donald NegroskiSarasota$1.4M
- Mark CascioneTampa$1.2M
- Lance KimOcala$1M
- Tuan VuTampa$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.